Response to tyrosine kinase inhibitors in myeloid neoplasms associated with
            
              PCM1
              ‐
              JAK2
            
            ,
            
              BCR‐JAK2
            
            and
            
              ETV6‐ABL1
            
            fusion genes

User: Guest

Document type:: Zeitschriftenaufsatz
Author(s):: Schwaab, Juliana; Naumann, Nicole; Luebke, Johannes; Jawhar, Mohamad; Somervaille, Tim C.P.; Williams, Mark S.; Frewin, Rebecca; Jost, Philipp J.; Lichtenegger, Felix S.; La Rosée, Paul; Storch, Nicola; Haferlach, Torsten; Horny, Hans‐Peter; Fabarius, Alice; Haferlach, Claudia; Burchert, Andreas; Hofmann, Wolf‐Karsten; Cross, Nicholas C.P.; Hochhaus, Andreas; Reiter, Andreas; Metzgeroth, Georgia
Title:: Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1 ‐ JAK2 , BCR‐JAK2 and ETV6‐ABL1 fusion genes
Journal title:: American Journal of Hematology
Year:: 2020
Fulltext / DOI:: doi:10.1002/ajh.25825
Publisher:: Wiley
E-ISSN:: 0361-86091096-8652
Date of publication:: 28.04.2020
BibTeX

Occurrences: